retatrutide is fda approved Letter regarding Retatrutide for weight loss: Study

Nutrition, science, and wellness must merge not collide, it says

Zepbound, the weight-loss version of Tirzepatide, added $2.31 billion in Q1 sales, bringing the total to $6.15 billion, making it Semaglutides biggest rival and a strong candidate for future top drug status

JPML issued an order on February 2, 2024 calling for the centralization of all GLP-1 gastroparesis lawsuits in the U.S

In addition to these three FDA-approved indications, Ozempic has gained widespread attention for its weight loss effects due to its ability to curb appetite and promote satiety

Everyone wins when there are good options for all tastes

It is an oral, small-molecule GLP-1 agonist